Effective natural food complements: anti-CoV-2 spike protein directed druggable inhibitors
Keywords:anti-CoV-2 spike protein, drugs, database
There is a number of photosynthetically produced small molecules that have previously been validated through SARS-CoV spike protein interaction assays for selectivity and effectivity in our database. Our specialty database, the AVIRA-DB, has been built from scientific papers that published results regarding selective & effective CoV-2 spike protein binding inhibitors that prevent virus binding to the Angiotensin Converting Enzyme type 2 (ACE2). These data have been accumulated since 2003, the time of the first well documented coronavirus pandemic. To develop our anti-viral nutraceutical capsule we favoured small molecules (Mw <1000 Dalton) from edible plant parts that are enriched in experimentally evaluated coronavirus inhibitors. From this “AVIRA-DB” we screened for local culture varieties of vegetables and spices that are enriched in the anti-viral hits. Thus, AVIRA is the first knowledge-based nutraceutical composition that was validated by selective anti-CoV-2’s spike protein assays, performed in silico, -vitro & -vivo. From Chemo- & Bio-text-mined meta-data from literature and patents resulted in druggable flavonoids and flavonols, which were validated as anti-CoV-2 spike protein directed small molecules that are preventing the binding of the virus to ACE2.
How to Cite
Copyright (c) 2020 Zoltan Olah, Laszlo Okresz, Ibolya Torok, Aniko Pestenacz, Aniko Harkai, Eva Kocsis
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
The original submitted version of the manuscript (the version that has not undergone peer review) may be posted at any time. Authors should disclose details of preprint posting, including DOI, upon submission of the manuscript to ECOCYCLES.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. LICENCE: Creative Commons Attribution 4.0 International (CC BY 4.0)